Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device.
Lieke NumanEmmeke AartsFaiz RamjankhanMarish I F J OerlemansManon G van der MeerNicolaas de JongeAnne-Marie OppelaarHans KempermanFolkert W. AsselbergsLinda W Van LaakePublished in: Journal of the American Heart Association (2024)
Time-dependent postoperative sST2 predicts all-cause mortality after left ventricular assist device implantation after adjustment for NT-proBNP. Future research is warranted into possible target interventions and the optimal monitoring frequency.